Tag: Cancer: Lymphoma
ASH: Axi-Cel CAR T-Cell Treatment Effective in High-Risk Lymphoma Patients
Five-year PFS was 28.5 percent and overall survival was 40.3 percent; 40.2 percent of patients did not meet ZUMA-1 eligibility criteria
Psychological Distress Reported for Indolent Non-Hodgkin Lymphomas
Overall, 45.8 percent of patients with iNHL are worried about prognosis; 31.2 percent perseverate on their prognosis
Poor Physical Function Persists in Childhood Cancer Survivors
Findings seen for patients diagnosed with acute lymphoblastic leukemia and non-Hodgkin lymphoma from the 1970s through the 1990s
Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab
Histopathologic findings included sprinkled distribution of small hyperchromatic lymphocytes in the upper epidermal section
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
Risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia elevated, but risks lower in recent years
Fracking Tied to Lymphomas, Asthma in New Study
The taxpayer-funded study followed a push by families of pediatric cancer patients
Many With Relapsed/Refractory Lymphoma in Pregnancy Delay Treatment
Five of 23 women studied received intentional antenatal therapy; no malformations or genetic diseases observed
Epkinly Granted Accelerated FDA Approval for Lymphoma
Approved for use in relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma
Small Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
Hazard ratios highest for patients exposed to immunomodulators and biologics or second-line biologics
Cancer Risk Increased With Exposure to Four or More CT Scans by Age 18
Increased risk of intracranial tumors, leukemia, and lymphoma by age 25 seen with exposure to four or more CT scans during childhood
